1,340
Views
3
CrossRef citations to date
0
Altmetric
Oncology

Evaluation of the health economic impact of initial diagnostic modality selection in patients suspected of having HCC in China and the USA

, , , , , & show all
Pages 1015-1029 | Received 14 Dec 2021, Accepted 03 Aug 2022, Published online: 19 Aug 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.